WeVote

Bill

Bill

HB 1310

Prescription Drug Repository Program - Revisions

2025 Regular Session Introduced by Harry Bhandari

HB 1310 revises Maryland's prescription drug disposal program to improve medication collection, safety, and environmental protection through updated operational requirements.

Approved by the Governor - Chapter 705
0
WeVote Research Nonpartisan
Bill Summary · HB 1310

Legislative bill overview

HB 1310 revises Maryland's Prescription Drug Repository Program, which collects unused or expired prescription medications from residents and safely disposes of them. The bill modifies the program's operations, administration, and participation requirements to improve medication disposal access and safety across the state.

Why is this important

Improper disposal of prescription drugs contributes to environmental contamination, water supply pollution, and drug misuse. By enhancing the repository program's structure and accessibility, the bill aims to increase participation rates and reduce dangerous medications entering landfills, waterways, or being diverted for misuse.

Potential points of contention

  • Program funding mechanisms – Revisions may shift costs between state agencies, pharmacies, or healthcare providers, affecting who bears financial responsibility
  • Participation requirements – Changes to which entities must participate (pharmacies, hospitals, clinics) could create compliance burdens or administrative costs for smaller providers
  • Privacy and tracking concerns – Enhanced collection systems may raise questions about how medication information is recorded and protected

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.